AMA CXO Todd Unger discusses the latest on COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering progress on Moderna’s and Pfizer’s EUAs, and identifying questions parents might have for physicians about getting their kids vaccinated.
Read MoreAMA CXO Todd Unger discusses FDA timeline on Pfizer & Moderna vaccines for the youngest children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA advisory committee’s recommendations for kids ages 6 to 17, news on a possible booster for fall, as well as the lifting of testing requirements for international travel to the U.S.
Read MoreAMA CXO Todd Unger reviews the timeline for COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID case numbers, what to expect this summer, how and why you should report positive at-home tests, as well as an increase in monkeypox cases in the U.S.
Read MoreHear the latest on who should receive the fourth dose of the COVID-19 booster—and when—and whether we’ll be seeing a vaccine for younger children soon. Susan R. Bailey, MD, immediate past president, AMA welcomes Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), addressing a host of hot topics related to the fourth dose booster vaccine and provide updates on pediatric vaccine safety data.
Read MoreOn this episode, Emily Volk, MD, FCAP, president of the College of American Pathologists, talks about the ins and outs of COVID-19 testing; knowing when to test, what test to take, and other pressing questions patients may have.
Read MoreAMA CXO Todd Unger reviews COVID-19 case trends coming out of the long weekend with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering Paxlovid treatments and «rebound infections,» monkeypox infections, and the AMA’s statement on the Texas elementary shootings that have devastated our nation.
Read MoreAMA CXO Todd Unger reviews the latest on vaccines for children ages 6 months through 4 years, as well as boosters for 5-11 year olds with AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. Also covering CDC’s recommendation on a second booster shot for people 50 or older, and the latest on the monkeypox outbreak.
Read MoreAMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.
For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers
Read MoreAMA CXO Todd Unger and Andrea Garcia, AMA’s director of science, medicine and public health, discuss the grim milestone of one million COVID deaths in the U.S. Also covering rising cases—especially in the Northeast and Midwest, where daily case reports are higher now than at the peak of 2021’s summer Delta surge. As well as news from last week’s second global COVID-19 vaccination summit.
Read MoreAMA CXO Todd Unger discusses the status of Covid vaccines for kids under 5 with Paul Offit, MD, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. Dr. Offit is also a member of the FDA’s vaccine advisory committee.
Read More